Item 4 is amended to include the following: Sinclair, Inc. (the "Reporting Person") notes that, on November 26, 2025, The E.W. Scripps Company (the "Issuer") announced the adoption of a shareholder rights plan, commonly known as a "poison pill". The Reporting Person believes that the strategic and financial rationale of a potential business combination with the Issuer is indisputable. Given the family control of the Issuer, the only effect of adopting a poison pill is to limit liquidity opportunities available for public shareholders of the Issuer. As requested by the Issuer, the Reporting Person submitted a proposal building upon prior constructive discussions between the parties. The Reporting Person intends to continue to engage with the Issuer in an effort to reach a mutually agreeable transaction that will deliver significant benefits to the Issuer's shareholders and local communities.